Results 271 to 280 of about 357,434 (340)

Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Chronic kidney disease (CKD) is a serious complication occurring in nearly one of three people with type 1 diabetes (T1D). Major therapeutic advances have been made in the management of CKD for people with type 2 diabetes (T2D), thereby improving their kidney, cardiovascular, and survival outcomes.
Katherine R. Tuttle, Linong Ji, Chantal Mathieu, Jonathan Rosen   +3 more
wiley   +1 more source

Dampness syndrome aggravates T helper 17/regulatory T imbalance to promote renal injury in rats with experimental membranous nephropathy. [PDF]

J Tradit Chin Med
Wenjun S, Haowen GU, Haiyu G, Ping LI, Yi W, Miaoru H, Houchun W, Xiaoyan H, Kun B.   +8 more
europepmc   +1 more source

Charge and size of mesangial IgA in IgA nephropathy

, 1985
Renato C. Monteiro, Lise Halbwachs‐Mecarelli, Maria Cristina Roque‐Barreira, Laure‐Hélène Noël, J Berger, Philippe Lesavre   +5 more
openalex   +1 more source

Efficacy and safety of iGlarLixi versus IDegAsp by baseline β‐cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli‐D study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare the efficacy and safety of insulin glargine 100 U/mL plus lixisenatide (iGlarLixi) with insulin degludec plus insulin aspart (IDegAsp) by β‐cell function in exploratory analyses of the Soli‐D study. Materials and Methods Soli‐D was a 24‐week, multicentre, randomised, open‐label study in Chinese adults with uncontrolled type 2 ...
Weijun Gu, Xiaohong Wu, Minlu Zhang, Xinyi Wang, Qin Du, Lei Kang, Felipe Lauand, Agustina Alvarez, Yiming Mu   +8 more
wiley   +1 more source

Large extracellular vesicles (microvesicles) in diabetic nephropathy: a systematic review of preclinical studies. [PDF]

Front Pharmacol
Ghanem SK, Abdelsalam SS, Bader L, Agouni A.   +3 more
europepmc   +1 more source

Salt-losing syndrome as a mimicker of the Nephroprotective effect of Gliflozins in Proteinuric nephropathies. [PDF]

Oxf Med Case Reports
Romano G, Nicholas F, Colussi G.
europepmc   +1 more source

Immunological abnormalities in patient with IgA nephropathy

, 1986
Chun Gyoo Ihm, Jeong‐Taek Woo, Young Woon Chang, O Sun Kwon, Myung Jae Kim   +4 more
openalex   +1 more source

Comparison of the renal outcomes of novel antidiabetic agents in patients with type 2 diabetes with chronic kidney disease: A systematic review and network meta‐analysis of randomized controlled trials

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To investigate the renal outcomes of dipeptidyl peptidase 4 (DPP‐4) inhibitors, glucagon‐like peptide‐1 (GLP‐1) receptor agonists, and sodium‐glucose transport protein‐2 (SGLT‐2) inhibitors in patients with type 2 diabetes mellitus (T2DM) with chronic renal disease (CKD).
Rong Lin, Chia‐Li Hsu, Ming‐Chieh Shih, Kuo‐Liong Chien, Hon‐Yen Wu   +4 more
wiley   +1 more source

Urinary Exosomes in Nephrology: A New Frontier for Diagnosis and Prognosis of Kidney Diseases. [PDF]

Int J Mol Sci
Gaudio C, D'Arpino E, Stefani S, Fani FM, Rosso G, Di Marcantonio E, Becherelli P, Caselli G, Merciai C, Fortunato L, Scopetani N, Rosati A.   +11 more
europepmc   +1 more source

Characterization of cationic albumin in minimal change nephropathy

, 1987
Gian Marco Ghiggeri, Fabrizio Ginevri, Giovanni Candiano, Roberta Oleggini, Francesco Perfumo, C Queirolo, R Gusmano   +6 more
openalex   +1 more source